NEW YORK ( TheStreet) -- GlaxoSmithKline (NYSE: GSK) hit a new 52-week high Thursday as it is currently trading at $46.86, above its previous 52-week high of $46.50 with 539,727 shares traded as of 9:35 a.m. ET. Average volume has been 2.1 million shares over the past 30 days. GlaxoSmithKline has a market cap of $113.66 billion and is part of the health care sector and drugs industry. Shares are up 1.6% year to date as of the close of trading on Wednesday. GlaxoSmithKline plc, together with its subsidiaries, engages in the discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health-related consumer products worldwide. The company has a P/E ratio of 13.8, below the average drugs industry P/E ratio of 14 and below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter